Macular Degeneration
A leading cause of vision loss affecting the central retina. Explore the underlying clinical research and the antioxidant potential of 9-cis in slowing progression.
Central Vision Impact
Age-related Macular Degeneration (AMD) affects the macula, the central part of the retina responsible for clear, sharp vision. It is categorized into 'dry' (atrophic) and 'wet' (neovascular) types, progressively impairing the ability to read and recognize faces.
Oxidative Stress
The progression of AMD is heavily driven by oxidative stress, lipofuscin accumulation, and chronic inflammation. The continuous cycle of visual perception generates intense levels of reactive oxygen species which slowly damage the pigment epithelium.
Antioxidant Defense
Phytochemicals and powerful antioxidants like natural 9-cis beta-carotene play a critical role in neutralizing free radicals and maintaining retinal structural integrity, slowing the degenerative cascades within macular cells.
Research Library
Access our curated database of clinical studies organized by health domain and year of publication.
Pharmacotherapy of retinal disease with visual cycle modulators.
9-cis-beta-carotene macular degeneration research offers hope for dry AMD patients. Learn how this visual cycle modulator works and current clinical trial status.
FDA Medical Disclaimer — These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Educational Purpose Only — The research and biomedical studies provided on this page are for informational and educational purposes only. They are intended to explain the mechanism of the 9-cis molecule. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.